Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

被引:79
|
作者
Ulldemolins, Marta [1 ,2 ,3 ]
Roberts, Jason A. [2 ,4 ,5 ]
Lipman, Jeffrey [2 ,4 ]
Rello, Jordi [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Crit Care Dept, Vall Hebron Univ Hosp, VHIR, Barcelona 08035, Spain
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] CIBERES, Barcelona, Spain
[4] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SEVERE SEPSIS; CLINICAL PHARMACOKINETICS; ANTIMICROBIAL THERAPY; GLOMERULAR-FILTRATION; ANTIBACTERIAL AGENTS; CREATININE CLEARANCE; HYPOALBUMINEMIA; PREDICTION;
D O I
10.1378/chest.10-2371
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although early and appropriate antibiotic therapy remains the cornerstone of success for the treatment of septic shock, few data exist to guide antibiotic dose optimization in critically ill patients, particularly those with multiple organ dysfunction syndrome (MODS). It is well known that MODS significantly alters the patient's physiology, but the effects of these variations on pharmacokinetics have not been reviewed concisely. Therefore, the aims of this article are to summarize the disease-driven variations in pharmacokinetics and pharmacodynamics and to provide antibiotic dosing recommendations for critically ill patients with MODS. The main findings of this review are that the two parameters that vary with greatest significance in critically ill patients with MODS are drug volume of distribution and clearance. Disease- and clinician-driven changes lead to an increased volume of distribution and lower-than-expected plasma drug concentrations during the first day of therapy at least. Decreased antibiotic clearance is common and can lead to drug toxicity. In summary, "front-loaded" doses of antibiotic during the first 24 11 of therapy should account for the likely increases in the antibiotic volume of distribution. Thereafter, maintenance dosing must be guided by drug clearance and adjusted to the degree of organ dysfunction. CHEST 2011; 139(5):1210-1220
引用
收藏
页码:1210 / 1220
页数:11
相关论文
共 50 条
  • [11] Monitoring Severity of Multiple Organ Dysfunction Syndrome: New and Progressive Multiple Organ Dysfunction Syndrome, Scoring Systems
    Typpo, Katri V.
    Lacroix, Jacques R.
    PEDIATRIC CRITICAL CARE MEDICINE, 2017, 18 : S17 - S23
  • [12] Multiple organ dysfunction syndrome after multiple trauma
    Walsh, CR
    ORTHOPAEDIC NURSING, 2005, 24 (05) : 324 - 333
  • [13] MORE for multiple organ dysfunction syndrome: Multiple Organ REanimation, REgeneration, and REprogramming
    Cobb, J. Perren
    CRITICAL CARE MEDICINE, 2010, 38 (11) : 2242 - 2246
  • [14] Refining the Pediatric Multiple Organ Dysfunction Syndrome
    Weiss, Scott L.
    Carcillo, Joseph A.
    Leclerc, Francis
    Leteurtre, Stephane
    Schlapbach, Luregn J.
    Tissieres, Pierre
    Wynn, James L.
    Lacroix, Jacques
    PEDIATRICS, 2022, 149 : S13 - S22
  • [15] Multiple Organ Dysfunction: The Defining Syndrome of Sepsis
    Ziesmann, Markus T.
    Marshall, John C.
    SURGICAL INFECTIONS, 2018, 19 (02) : 184 - 190
  • [16] Multiple organ dysfunction syndrome: a narrative review
    David Johnson
    Irvin Mayers
    Canadian Journal of Anesthesia, 2001, 48 : 502 - 509
  • [17] Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome
    Carcillo, Joseph A.
    Podd, Bradley
    Aneja, Rajesh
    Weiss, Scott L.
    Hall, Mark W.
    Cornell, Timothy T.
    Shanley, Thomas P.
    Doughty, Lesley A.
    Nguyen, Trung C.
    PEDIATRIC CRITICAL CARE MEDICINE, 2017, 18 : S32 - S45
  • [18] Multiple organ dysfunction syndrome in humans and dogs
    Johnson, V
    Gaynor, A
    Chan, DL
    Rozanski, E
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2004, 14 (03) : 158 - 166
  • [19] Multiple Organ Dysfunction Syndrome in Humans and Animals
    Osterbur, K.
    Mann, F. A.
    Kuroki, K.
    DeClue, A.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2014, 28 (04) : 1141 - 1151
  • [20] Apoptosis in sepsis and multiple organ dysfunction syndrome
    Zeerleder, S
    Zwart, B
    Wuillemin, WA
    Aarden, LA
    Groeneveld, ABJ
    Caliez, C
    van Nieuwenhuijze, AEM
    van Mierlo, GJ
    Eerenberg, AJM
    Lämmle, B
    Hack, CE
    ADVANCES IN CRITICAL CARE TESTING, 2004, : 3 - 13